Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia (Q35055199)

6 August 2017

1 reference

title

Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia (English)

1 reference

6 August 2017

0 references

4

Joseph Loscalzo

1 reference

6 August 2017

Norbert Weiss

1

1 reference

6 August 2017

Christiane Keller

series ordinal

2

1 reference

6 August 2017

Ulrich Hoffmann

series ordinal

3

1 reference

6 August 2017

language of work or name

1 reference

1 August 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

227-239

1 reference

Regulatory functions of the vascular endothelium

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine and risk of cardiovascular disease among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine and ischaemic heart disease in the Caerphilly cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Association of plasma homocysteine with the number of major coronary arteries severely narrowed

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Endothelial control of vascular tone in large and small coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nitric oxide and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Systemic nature of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nitric oxide and coronary endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nitric oxide as a signaling molecule in the vascular system: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Cellular regulation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Flow-induced constriction in arterioles of hyperhomocysteinemic rats is due to impaired nitric oxide and enhanced thromboxane A(2) mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

The effects of oral methionine and homocysteine on endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

The oxidant stress of hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Ultrasound imaging-guided noninvasive ultrasound thrombolysis: preclinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Heparin-induced release of extracellular superoxide dismutase to human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Heparin-Induced Release of Extracellular-Superoxide Dismutase Form (V) to Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Induction of oxidative stress by homocyst(e)ine impairs endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Cellular glutathione peroxidase deficiency and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Structural requirements for oxidation of low-density lipoprotein by thiols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine inhibits inactivation of factor Va by activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Oxidative stress and platelet activation in homozygous homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Letter: Factor-VIII complex and endothelial damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

Glutathione Peroxidase Protects against Peroxynitrite-mediated Oxidations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1358863X02VM428RA

10.1191/1358863X02VM428RA

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference